Publication | Open Access
Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcoma
76
Citations
24
References
2019
Year
This study provides evidence of positive drug activity for pazopanib in conventional chondrosarcoma.
| Year | Citations | |
|---|---|---|
Page 1
Page 1